TAIPEI, Taiwan, May 9 /Xinhua-PRNewswire-FirstCall/ -- Advanced Semiconductor Engineering, Inc. (NYSE: ASX, TAIEX: 2311, 'ASE Inc.') and its majority-owned subsidiary ASE Test Limited (Nasdaq: ASTSF, TAIEX: 9101, "ASE Test') today announced May 30, 2008 as the anticipated effective date of the proposed 'going private' acquisition by ASE Inc. of the outstanding ordinary shares of ASE Test that ASE Inc. does not directly or indirectly own by way of a scheme of arrangement under Singapore law (the 'Scheme'). ASE Inc. and ASE Test announced on May 6, 2008 that the Scheme was approved by the requisite majority of unaffiliated shareholders of ASE Test at the May 6, 2008 meeting of shareholders of ASE Test convened by the order of the High Court of Singapore (the 'Court'). ASE Test applied on May 7, 2008 to the Court to sanction the Scheme, and a Court hearing to sanction the Scheme is scheduled to take place on May 22, 2008. The Scheme will only become effective when the order of the Court sanctioning the Scheme is lodged with the Accounting and Corporate Regulatory Authority of Singapore (the 'ACRA'). ASE Inc. and ASE Test currently anticipate that the Scheme will become effective on May 30, 2008, pending the receipt of the order of the Court sanctioning the Scheme, the lodging of such order with the ACRA and the satisfaction of other customary closing conditions. The books closure date for determining the entitlements of shareholders of ASE Test under the Scheme is expected to be the same date as the effective date of the Scheme. About ASE Inc. ASE Inc. is one of the world's largest independent provider of integrated circuit ('IC') packaging services and, together with its majority owned subsidiary ASE Test Limited, the world's largest independent provider of IC testing services, including front-end engineering test, wafer probe and final test services. ASE Inc. currently has approximately more than 200 international customers. With advanced technological capabilities and a global presence spanning Taiwan, Korea, Japan, Singapore, Malaysia and the United States, ASE Inc. has established a reputation for reliable, high quality products and services. For more information, visit our website at http://www.aseglobal.com/ . The common shares of ASE Inc. are listed on the Taiwan Stock Exchange under the symbol '2311'. The American Depository Receipts of ASE Inc. are listed on the New York Stock Exchange under the symbol 'ASX'. The directors of ASE Inc. (including any director who may have delegated detailed supervision of this press release) have taken all reasonable care to ensure that the facts stated and opinions expressed in this press release (other than those relating to ASE Test) are fair or accurate and that no material facts have been omitted from this press release and they jointly and severally accept responsibility accordingly. Where any information has been extracted from published or publicly available sources or obtained from ASE Test, the sole responsibility of the directors of ASE Inc. has been to ensure, through reasonable enquiries, that such information is accurately extracted from such sources or, as the case may be, reflected or reproduced in this press release. About ASE Test ASE Test is one of the world's largest independent providers of semiconductor testing services. It provides customers with a complete range of semiconductor testing services, including front-end engineering test, wafer probe, final test and other test-related services. The ordinary shares of ASE Test are quoted for trading on The NASDAQ Global Market under the symbol 'ASTSF'. ASE Test's Taiwan Depository Shares, which represent its ordinary shares, are listed for trading on the Taiwan Stock Exchange under the symbol '9101'. The directors of ASE Test (including any director who may have delegated detailed supervision of this press release) have taken all reasonable care to ensure that the facts stated and opinions expressed in this press release are fair or accurate and that no material facts have been omitted from this press release and they jointly and severally accept responsibility accordingly. Where any information has been extracted from published or publicly available sources, the sole responsibility of the directors of ASE Test has been to ensure, through reasonable enquiries, that such information is accurately extracted from such sources or, as the case may be, reflected or reproduced in this press release. Forward-Looking Statements All statements other than statements of historical facts included in this press release are or may be forward-looking statements. Forward-looking statements include, but are not limited to, those using words such as "seek", "expect", "anticipate", "estimate", "believe", "intend", "project", "plan", "strategy", "forecast" and similar expressions or future or conditional verbs such as "will", "would", "should", "could", "may" and "might". These statements reflect ASE Inc.'s or ASE Test's (as the case may be) current expectations, beliefs, hopes, intentions or strategies regarding the future and assumptions in light of currently available information. Such forward-looking statements are not guarantees of future performance or events and involve known and unknown risks and uncertainties. Accordingly, actual results may differ materially from those described in such forward-looking statements. Shareholders and investors should not place undue reliance on such forward-looking statements, and ASE Inc. and ASE Test undertake no obligation to update publicly or revise any forward-looking statements. For further information please contact: ASE Inc. Freddie Liu (Vice President) Tel: +8862 8780-5489 Email: ASE Test Ken Hsiang (CFO) Tel: +1-510-687-2475 Email: MacKenzie Partners (UK) Limited (Proxy Solicitation Agent) Michael Diaz Tel: +44-207-170-4155 DATASOURCE: Advanced Semiconductor Engineering, Inc.; ASE Test Limited CONTACT: Freddie Liu (Vice President) of ASE Inc., +8862 8780-5489, or ; or Ken Hsiang (CFO) of ASE Test, +1-510-687-2475, or ; or Michael Diaz of MacKenzie Partners (UK) Limited (Proxy Solicitation Agent), +44-207-170-4155, for ASE

Copyright